Study: Heart-failure patients benefit from Medtronic device

03/31/2009 | Wall Street Journal, The · Bloomberg

A two-year clinical trial found that Medtronic's cardiac resynchronization therapy device combined with drug therapy was more effective in delaying the worsening of symptoms in patients with mild heart failure than using medication alone. The positive results could provide a boost to a larger study on CRT devices sponsored by Boston Scientific, an analyst said.

View Full Article in:

Wall Street Journal, The · Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT